POPULARITY
Categories
Dr Rashmi Chugh from Rogel Comprehensive Cancer Center in Ann Arbor, Michigan, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize major clinical findings presented at the 2025 ASCO Annual Meeting for patients with soft tissue sarcoma and other connective tissue neoplasms. CME information and select publications here.
In this weeks podcast from VJOncology, five leading experts share updates and insights on the evolving landscape of precision medicine... The post Sarcoma awareness month: advances in precision medicine appeared first on VJOncology.
Featuring perspectives from Dr Rashmi Chugh and Dr Mrinal Gounder, including the following topics: Introduction: Current Role of General Medical Oncologists in the Treatment of Soft Tissue Sarcomas (STS) (0:00) Incorporation of Novel Agents and Strategies into the Management of STS — Faculty Presentation (6:38) Incorporation of Novel Agents and Strategies into the Management of STS — Survey Questions (20:34) Evolving Treatment Paradigm for Locally Aggressive STS — Faculty Presentation (31:09) Evolving Treatment Paradigm for Locally Aggressive STS — Survey Questions (46:44) CME information and select publications
Amy Dixon took her then 9 year old son Ben to his pediatrician and many specialists early in 2019 to find out what was the cause of the leg pain that had been bothering him. The one thing that these doctors agreed about was that it was NOT Cancer related. Unfortunately however, that was not the case. Ben was finally diagnosed with the Bone Cancer Ewings Sarcoma and after his first treatment protocol was declared to be in remission. 3 months later, in June of 2020, Ben relapsed which led to his sudden passing on July 8th of 2021 .
July is Sarcoma awareness month!! A diagnosis of sarcoma can have a lasting impact on patients and families. For those who have been diagnosed and their families, there are resources and groups dedicated to educate, support and raise awareness. In this episode we highlight the MIBagents! A nonprofit organization dedicated to creating a better community and support for patients with pediatric osteosarcoma and their families. They accomplish this through many various patient programs, engaging clinicians, scientists and patients. Links https://www.mibagents.org Sarcoma strong Annual 5k - https://www.zippy-reg.com/online_reg/index.php?e=2167&rfrl=leIOZdAxZ%2BA724wBbO5ycg%3D%3D Team - UMMC Orthopaedics Find out More about our Doctors: Dr. Izuchukwu Ibe: www.linkedin.com/in/izuchukwu-ibe-a073537a/ Dr. Elyse Brinkmann: www.linkedin.com/in/elyse-brinkmann/
BUFFALO, NY - July 18, 2025 – A new #editorial was #published in Volume 16 of Oncotarget on July 16, 2025, titled “microRNAs in soft tissue sarcoma: State of the art and barriers to translation.” In this article, Elizaveta K. Titerina, Alessandro La Ferlita, and Joal D. Beane from Ohio State University discuss the role of microRNAs in soft tissue sarcomas (STS), a rare and diverse group of cancers that begin in connective tissues, like bone or fat. The authors explain how these small molecules regulate cancer-related processes and highlight their potential as non-invasive biomarkers for diagnosis and monitoring. They also outline the main challenges that need to be addressed before microRNA-based strategies can be used in clinical settings. Soft tissue sarcomas include over 50 subtypes, making precise diagnosis and effective treatment difficult. The editorial describes how microRNAs influence cancer growth, spread, and response to therapies. Because microRNAs are stable in body fluids like blood and saliva, they could be used for early detection and to help guide treatment decisions. Such as, certain groups of microRNAs are linked to how patients respond to specific drugs, showing their potential as tools for precision medicine. “For example, miR-17-92 and miR-106b-25 clusters have been associated with sensitivity or resistance to eribulin in STS.” The authors also explain that microRNAs could help distinguish between tumor types that are often difficult to differentiate, such as benign lipomas and malignant liposarcomas. Recognizing these differences is crucial for guiding treatment decisions. Specific patterns of microRNA expression in blood samples may enable clinicians to make quicker and more reliable diagnoses without the need for invasive procedures. Beyond their diagnostic role, microRNAs are also being explored as therapeutic tools, but applying microRNA-based therapies to patients remains challenging. These molecules can act as either cancer promoters or suppressors, depending on the environment, which complicates the development of safe and targeted treatments. However, new delivery methods such as lipid nanoparticles show promise in improving precision and safety. Overall, microRNAs are emerging as an important focus in STS research, offering new possibilities for advancing diagnosis, prognosis, and treatment. As researchers continue to address the current challenges, these small molecules could become valuable tools in improving cancer care. DOI - https://doi.org/10.18632/oncotarget.28754 Correspondence to - Joal D. Beane, joal.beane@osumc.edu Video short - https://www.youtube.com/watch?v=MlLGA8BObPQ Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28754 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, soft tissue sarcoma, liposarcoma, microRNA, small non-coding RNA, cancer biomarkers To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM
La Capilla del Centro Cultural Torrente Ballester acogerá esta tarde a partir de las 20.00 horas, una jornada de concienciación sobre el sarcoma, organizada por la Asociación de Sarcomas de Galicia (ASARGA) en colaboración con el Concello de Ferrol. El acto incluirá la proyección del documental «O Sarcoma Día a Día», una pieza audiovisual que recoge los testimonios de pacientes que conviven con este tipo de cáncer poco frecuente. El documental busca visibilizar sus experiencias diarias, los retos a los que se enfrentan y la fortaleza con la que afrontan la enfermedad. Mayte Deus, presidenta de Asarga, anima a toda la ciudadanía a asistir y participar en esta iniciativa solidaria, y agradece el apoyo constante de la Concejalía de Política Social e Inclusión. Además, destacó el éxito del I Festival Solidario de Asarga, celebrado el año pasado en el Teatro Jofre, como ejemplo del compromiso institucional con la causa. La entrada será libre hasta completar aforo. La actividad está dirigida tanto al público general como a profesionales sanitarios, familiares de pacientes y colectivos sociales, con el objetivo de fomentar la sensibilización y el conocimiento sobre el sarcoma.
Sarcoma is rare but the need for awareness is urgent. This lesser-known group of cancers often goes undetected until it's advanced, making early diagnosis difficult and treatment more complex. In our latest episode, we're shedding light on what sarcoma is, the early warning signs, the hurdles in diagnosis, and the progress in research that's giving patients better options and hope.If you're in healthcare, patient advocacy, or simply want to be more informed, this conversation matters. Listen, share, and help amplify the message. Only on TALRadio English.Host : MadhaviExpert : Kaumudi Bhawe#TALRadioEnglish #SarcomaAwareness #CancerAwareness #HealthEducation #Oncology #RareCancer #PatientSupport #EarlyDetection #CancerCare #HealthcareProfessionals #PublicHealth #MedicalResearch #TouchALife #TALRadio
What happens when cancer strikes in your 20s or 30s? How do you navigate life-changing diagnoses during the most formative years of your life? In this powerful episode of All Talk Oncology, Kenny Perkins speaks with Dr. Venkataraman, a young adult cancer specialist at Dana-Farber Cancer Institute, who is deeply committed to caring for patients with rare cancers like sarcoma. From the emotional trauma of delayed diagnoses to the complexities of survivorship, Dr. V shares how he supports patients not just through treatment—but through rediscovering their lives afterward. Key topics discussed: Why young adults are often diagnosed late—and what we can do about it How sarcoma differs from other cancers and why it's so misunderstood Treatment challenges: surgery, radiation, chemotherapy, and their impact Why survivorship care is just as important as treatment The mental health struggles cancer patients rarely talk about The role of personalized care: meeting patients where they are Advances in sarcoma research, clinical trials, and treatment protocols Empowering patients to take charge of their own journey Creative outlets for physicians: how Dr. V uses reflective writing to process the emotional weight of oncology Immortalize your voice by being an ALL TALK ONCOLOGY GUEST! Just fill-out this FORM. SOCIAL MEDIA LINKS: All Talk Oncology: Instagram & Facebook JOIN OUR FREE COMMUNITY: Facebook Community WEBSITE: https://www.alltalkoncology.com
The James Sarcoma Program continues to grow, with the recent opening of the multidisciplinary Sarcoma Clinic, new and cutting-edge clinical trials and a project in Ecuador to train doctors to treat sarcoma patients. “The entire continuum of cancer care is improving and that's why it's important to have a multi-disciplinary team and clinic, so patients have access to all these advances,” said Joel Mayerson, MD, director of the James Sarcoma Program. Mayerson described the recent advances made by the Sarcoma Program. A renowned sarcoma surgeon, in recent years Mayerson has been utilizing 3D printing to create replacement “bones” for sarcoma patients. “We can take scans and create [with the 3D printer] ‘bones' the exact size of what we remove.” In a new clinical trial “we've found that if we give immunotherapy concurrently with radiation therapy it helps the radiation works better,” Mayerson said, adding “we have the first proton radiation center in Ohio and that allows us to hone the beam to a smaller area and damages less tissue.” Mayerson and the sarcoma team have been collaborating with the world-class veterinarians at Ohio State Veterinary Medical Center to create a probe that allows surgeons to see, in real time during surgery, the difference between normal tissue and tumorous tissue. Seeing the difference enables surgeons to remove less normal tissue, which leads to better function and quality of life for patients. “We used pilot data funded by Steps for Sarcoma to apply for and receive an Ohio State President's Accelerator grant,” Mayerson said. Steps for Sarcoma is the annual fundraising walk; the next Steps will be held September 21. After operating on a patient from Ecuador, Mayerson and the sarcoma team “were asked to help build the program there,” he said. An Ecuadorian surgeon spent a year at the James working with Mayerson and his team, additional physicians will be trained and “our sarcoma tumor board helps guide them in treating their sarcoma patients … This has been one of the most satisfying things I've done in my career, to know that we're impacting patients a couple thousand miles away.”
Sarcoma is deadliest cancer among children and young people, accounting for nearly one third of deaths among the 15-24 age group. Despite this, research funding remains low compared to more common cancers, and feeds back into low survival rates. It's also reportedly misdiagnosed a third of the time, highlighting the urgent need for better early detection. What do we do if we feel like our doctors misdiagnosed us? What signs should we look out for? How can we balance cancer-research to address the common ones and the deadliest ones? Orthopaedic Surgeon Andrew Johnston joins Tim Beveridge for the Health Hub... LISTEN ABOVE See omnystudio.com/listener for privacy information.
Dù chỉ chiếm 1% các ca ung thư ở người lớn, sarcoma lại gây ra tới một phần ba các ca tử vong do ung thư ở thanh thiếu niên Úc. Các chuyên gia kêu gọi nâng cao nhận thức và đầu tư nhiều hơn vào nghiên cứu để cứu sống những người trẻ.
La Asociación de Sarcomas Grupo Asistencial (ASARGA) se suma un año más a la conmemoración del Día Internacional del Sarcoma, que se celebra el próximo 13 de julio, con un extenso programa de actividades destinadas a visibilizar esta enfermedad rara, sensibilizar a la ciudadanía y recaudar fondos para apoyar a pacientes y familiares. Este año, la conmemoración tendrá un significado especialmente emotivo tras el reciente fallecimiento de Iara Mantiñán Bua, una de las fundadoras de ASARGA, referente en la lucha contra el sarcoma y ejemplo de fortaleza y entrega. La asociación rendirá homenaje a su figura durante los actos previstos, recordándola como una luchadora incansable cuya memoria seguirá impulsando el trabajo de la entidad. Entre las acciones más destacadas figura la colaboración con la Asociación Cultural Son d’aquí, durante la celebración del tradicional Serán, que tendrá lugar en A Coruña del 11 al 13 de julio. Este festival popular, que este año celebra su 10º aniversario, dedicará parte de su recaudación a la lucha contra el sarcoma. ASARGA aprovechará este marco para lanzar una camiseta solidaria conmemorativa, disponible tanto en su sede como en su página web y en varios comercios del barrio de Montealto. Además, se habilitará un puesto solidario los días 11 y 12 de julio en la Plaza de España, donde también se celebrará un bingo solidario el sábado a las 19:00 horas. Los premios han sido donados por el Real Club Deportivo de A Coruña, incluyendo camisetas, sudaderas y un equipamiento completo del club. Las actividades de concienciación ya comenzaron en junio, con la presentación del libro y documental “El sarcoma día a día”, que recoge testimonios de pacientes reales. En colaboración con el Concello de Ferrol, el documental se proyectará el próximo 18 de julio en el Centro Cultural Torrente Ballester. Mayte Deus, presidenta de ASARGA, ha querido subrayar la importancia de estas iniciativas: “Invitamos a toda la comunidad a participar. Visibilizar el sarcoma es vital, y recordar a personas como Iara nos recuerda por qué seguimos luchando cada día”.
In this episode, Vera spoke with Dr. Alessandra Maleddu, a medical oncologist and sarcoma specialist at the University of Colorado. Dr. Maleddu specializes in soft tissue and bone sarcomas, with a particular focus on desmoid tumors and advancing clinical trials in this rare disease area. Desmoid tumors are locally invasive soft tissue tumors that present unique diagnostic and treatment challenges, as they can vary significantly from patient to patient and are often misdiagnosed. Women are two to three times more likely than men to be diagnosed with a desmoid tumor. Dr. Maleddu trained in Italy and the UK, completing a sarcoma fellowship at University College London Hospital, general oncology training at the University of Bologna and earning her MD from the University of Cagliari in Italy. Tune in to hear how Dr. Maleddu is helping lead in the sarcoma space, with a focus on desmoid tumors. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Welcome to Season 2 of the Orthobullets Podcast.Today's show is Foundations, where we review foundational knowledge for frontline MSK providers such as junior orthopaedic residents, ER physicians, and primary care providers.This episode will cover the topic of Ewing's Sarcoma, from our Pathology section at Orthobullets.com.Follow Orthobullets on Social Media:FacebookInstagram TwitterLinkedInYouTube
Tumores óseos: ¿Qué son, sus síntomas y tratamiento?Para hablar de este tema nos acompañó el Dr. Luis Willians, Traumatólogo y oncólogo ortopedista. Especialista en tumores óseos.Un tumor óseo es una proliferación anormal de células dentro de un hueso. Este tipo de tumor puede ser canceroso (maligno) o no (benigno).¿Cuáles son los síntomas?En cuanto a los síntomas, el dolor puede ser poco intenso y localizado. Cuando aparecen síntomas como pérdida de peso, astenia o fiebre, hay que pensar en la existencia de un tumor maligno.Los pacientes que padecen Sarcoma de Ewing avanzado pueden presentar también fiebre y afectación del estado general.La causa de los tumores óseos se desconoce. A menudo se presentan en áreas del hueso que crecen rápido. las posibles causas incluyen: anomalías genéticas hereditarias, radiación y alguna lesión. En la mayoría de los casos, no se encuentra ninguna causa específica.Los cánceres que comienzan en los huesos se denominan tumores óseos primarios. Los cánceres de hueso que comienzan en otra parte del cuerpo (como las mamas, los pulmones o el colon) se denominan tumores secundarios o Tumores Óseos metastásicos.
Waiting for a proper cancer diagnosis for 9 months is something that should never happen, especially when the doctor says that the chances of cancer on a 1-10 scale were ZERO in his opinion. Unfortunately that is what happened to Jen and Will Fox in regards to their then 8 year old son who was finally diagnosed with Ewings Sarcoma in the winter of 2018, and passed away on May 25th of 2021.
26 May 2025 - Strong results in soft tissue sarcoma have capped off a busy quarter of immunotherapy progress
Following a brief break, there is no better time for a brief review and catch up. During this episode we go over some commonly used terminology and processes along the sarcoma timeline with the new addition to our team, and host Dr. Sarah Ballatori
Exploring the growing role of DNA methylation in classifying and predicting prognosis for sarcomas, while highlighting integration with array, NGS, and CNV analysis for complex profiling. And other tumors and applications Hosted on Acast. See acast.com/privacy for more information.
Dr Bill Nelson talks with Dr Christine Pratilas, the new Director of Pediatric Oncology at the Johns Hopkins Kimmel Cancer Center, about the care of children with sarcoma and the importance of research funding in discovering new treatments for childhood cancers.
In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Joan Carles, Head of Section for the Genitourinary, Central Nervous System, Sarcomas and Tumours of Unknown Origin Unit at Vall d'Hebron University Hospital. Carles discusses breakthroughs in genitourinary cancer and sarcoma treatment, including anti-angiogenic therapies, overcoming resistance, and the role of genetic polymorphisms in personalised medicine. Timestamps: 00:00 – Introduction 01:56 – Anti-angiogenic therapies 05:03 – Treatment resistance 07:53 – Genetic polymorphisms 09:02 – Sarcoma treatments 11:16 – Novel drugs 15:22 – Oncology societies 18:00 – Carles' three wishes for healthcare
· In this podcast a patient with sarcoma and a specialist sarcoma nurse discuss the patient's journey from initial diagnosis through to treatment and recovery. They will also discuss the physiological, emotional and mental impact that sarcoma had, as well as the critical role of the cancer nurse specialist within the treatment plan, alongside a patient support group. Listeners to the podcast will gain a better understanding of the challenges in diagnosing soft-tissue sarcoma, the tools that are already available to assist physicians in diagnosis, and the importance of providing patients with clear information throughout the treatment journey. This podcast is published open access in Oncology and Therapy and is fully citeable. You can access the original published podcast article through the Oncology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40487-025-00342-6. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Imagine the shock and horror of having a child be diagnosed with Acute Myeloid Leukemia, going through treatment for that for 8 months,, relapsing 2 months later, and then being told that the first diagnosis was wrong, and that the child actually had Ewings Sarcoma. That is what happened to then 2 1/2 year old Connor Mocey who is now 5 years old and doing as well as possible while dealing with this difficult Bone Cancer.
Katie Histing was diagnosed with Ewings Sarcoma when she was a 17 year old High School Senior in 2018. Katie fought her disease like a true Champion, made countless friends along the way and will always be known as a Pediatric Cancer Icon. Katie passed away on November 25th of 2024, approximately 6 months after Katie was told that there were no more curative options for her.
In this episode of the Cyber Uncut podcast, David Hollingworth and Daniel Croft talk about Chris Krebs' extraordinary decision to step down from SentinelOne in order to fight the Trump administration, an array of hacks both global and local, and the importance of funding the essential CVE Program. And China has made fascinating claims about US activity against the Asian Winter Games earlier this year. Hollingworth and Croft kick things off with Chris Krebs, who announced his resignation from SentinelOne this week following the signing of an executive order revoking his security clearance. He doesn't want to distract from SentinelOne's work, and he plans on taking this fight to the US government. Croft and Hollingworth then catch up on the week in cyber crime, with the 4chan message board getting hacked by a rival board, car rental giant Hertz Australia confirming it was caught up in a global Hertz data breach, and local outfit TMA Group of Companies falling victim to Sarcoma ransomware attack. The podcast wraps up with the pair talking about funding uncertainty involving the vital vulnerability-tracking CVE Program and how important the program is as a frontline tool against hackers and nation-state actors. Enjoy the podcast, The Cyber Uncut team
Ginny Curtin is living with sarcoma. She's not just surviving- she's thriving and sharing her perspective with fellow patients. This includes amazing adventures packed with incredible photography.
Featuring perspectives from Dr Rashmi Chugh and Dr Richard F Riedel, including the following topics: Other Connective Tissue Neoplasms — Dr Chugh (0:00) Sarcoma — Dr Riedel (28:16) CME information and select publications
Dr Bill Nelson talks with Dr Christian Meyer about being named the Johns Hopkins Hospital Physician of the Year and treating patients with sarcoma. Read more ➡️ https://bit.ly/3XFAt2R
Interview with Jade Homsi, MD
This featured podcast brings together 2 experts to discuss the care of patients with epithelioid sarcoma.
Osteosarcoma Webinar Series: Sowmya Ramesh, PhD joins us on OsteoBites to discuss how multi-modal omics analysis identifies targetable sensory neuron circuitry that promotes sarcoma disease progression.Bone pain is a hallmark of bone cancers, including osteosarcoma (OS), mediated by skeletal-innervating peripheral afferent neurons. However, the roles of tumor-associated sensory neurons in OS beyond pain perception remain poorly understood. To investigate their regulatory functions, a chemical-genetic approach was employed in mice carrying a knock-in allele for TrkA to perturb sensory nerve innervation during OS growth and progression. TrkA inhibition in these transgenic mice significantly reduced sarcoma-associated sensory innervation and vascularization, altered tumor-associated macrophage polarization, decreased tumor growth and metastasis, and extended overall survival.These findings suggest that targeting pathological innervation in OS may serve as an adjunctive therapy to enhance clinical outcomes and survival.Dr. Ramesh is a postdoctoral researcher from the James lab at Johns Hopkins. The lab's research focus lies at the intersection of skeletal pathophysiology and stem cell biology. The lab looks at the interaction of nerves in various musculoskeletal repair including bone repair and regeneration, osteoprogenitor cell characterization, and neoplastic bone. Dr. Ramesh specifically works on understanding how peripheral nerves regulate osteosarcoma disease progression.
U.S. lawmakers demand UK retraction of Apple backdoor Sarcoma ransomware claims breach at giant PCB maker Unimicron Ransomware attack disrupts Michigan's Sault Tribe operations Huge thanks to our sponsor, Vanta Do you know the status of your compliance controls right now? Like...right now? We know that real-time visibility is critical for security, but when it comes to our GRC programs…we rely on point-in-time checks. But more than 9,000 companies have continuous visibility into their controls with Vanta. Vanta brings automation to evidence collection across over 35 frameworks, like SOC 2 and ISO 27001. They also centralize key workflows like policies, access reviews, and reporting, and helps you get security questionnaires done 5 times faster with AI. Now that's…a new way to GRC. Get started at Vanta.com/headlines Find the stories behind the headlines at CISOseries.com.
What was thought to be a sprained ankle became a completely different situation for 10 year old Rachel Webster when she was diagnosed with Ewings Sarcoma. Rachel just turned 13 and is doing as well as possible after her battle and living as good of a life as she can. Her mom Marcy will talk about her daughter and the way that she has been able to overcome many obstacles as she now has No Evidence Of Disease.
In today's episode, we had the pleasure of speaking with Yvonne Mowery, MD, PhD, about the phase 2 SU2C-SARC032 trial (NCT03092323) investigating the addition of pembrolizumab to preoperative radiotherapy and surgery in patients with soft-tissue sarcoma. Dr Mowey is a physician scientist and an associate professor of radiation oncology at the University of Pittsburgh Medical Center Hillman Cancer Center in Pennsylvania. In our exclusive interview, Dr Mowery discussed unmet needs for patients with soft-tissue sarcoma that prompted the initiation of this research, key efficacy and safety findings from the trial, and potential next steps for investigating the treatment regimen in this patient population.
Raising awareness about sarcoma is essential to reducing treatment delays and preventing misdiagnoses of this rare cancer with over 100 subtypes. The Association of Cancer Care Centers (ACCC) is dedicated to providing up-to-date information on sarcoma management and the unique challenges associated with diagnosis and treatment in community settings. In this episode, CANCER BUZZ speaks with Richard Riedel, MD, professor of medicine at Duke Cancer Institute, to explore the critical resources needed for sarcoma care, including psychosocial support and the financial difficulties often faced by patients. Dr Riedel also discusses the future of treatment options in community-based settings and the importance of collaboration between community providers and academic/specialty centers. Additionally, CANCER BUZZ speaks with Katie Wintergerst, a sarcoma patient, who shares her personal journey and the challenges she encountered on her path to diagnosis. “It's critically important to partner with centers with disease-specific expertise, academic centers, for example, that are well-positioned to partner with community-based providers in providing optimal care for patients.” – Richard Riedel, MD “What I've had to become comfortable with ... is that clinical trials can be tricky and they can be scary, but in the world of sarcoma, there haven't been a lot of new products FDA-approved for treatment. Clinical trials is where the work is going on.” -Katie Wintergerst Richard Riedel, MD Professor of Medicine Duke Cancer Institute Durham, NC Katie Wintergerst Sarcoma Patient Resources: ACCC Sarcoma Resources for Providers and Patients SFA Clinical Trials Resource Center Sarcoma Treatment Centers
This DermSurgery Digest bonus content aptly named “At the Microscope” shares the latest research and techniques in dermatopathology. In this episode, we will review Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma. Contributors to this podcast include Naomi Lawrence, MD, Dermatologic Surgery Digital Content Editor; Ashley Elsensohn, MD, MPH, DermSurgery Digest at the Microscope co-host; Christine Ahn, MD; Jeff Gardner, MD; Marina K. Ibraheim, MD; and Michael P. Lee, MD.Articles Reviewed: Agaimy A. The many faces of Atypical fibroxanthoma. Semin Diagn Pathol. 2023 Jul;40(4):306-312. doi: 10.1053/j.semdp.2023.06.001. Epub 2023 Jun 23. PMID: 37438163. Link: https://pubmed.ncbi.nlm.nih.gov/37438163/ Ørholt M, Abebe K, Aaberg F, Rasmussen LE, Daugaard S, Loya AC, Herly M, Vester-Glowinski PV. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis. Am J Dermatopathol. 2022 Dec 1;44(12):913-920. doi: 10.1097/DAD.0000000000002305. PMID: 36395448. Link: https://pubmed.ncbi.nlm.nih.gov/36395448/van Midden D, Flucke UE, Amir AL, Bonenkamp JJ, Lubeek SFK, Blokx WAM. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX? Ann Diagn Pathol. 2022 Jun;58:151915. doi: 10.1016/j.anndiagpath.2022.151915. Epub 2022 Feb 10. PMID: 35276548. Link: https://pubmed.ncbi.nlm.nih.gov/35276548/Anders IM, Schimmelpfennig C, Wiedemann K, Löffler D, Kämpf C, Blumert C, Reiche K, Kunz M, Anderegg U, Simon JC, Ziemer M. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges. 2023 May;21(5):482-491. doi: 10.1111/ddg.15006. Epub 2023 Apr 10. PMID: 37035902. Link: https://pubmed.ncbi.nlm.nih.gov/37035902/ Listeners are encouraged to submit questions for podcast hosts to answer in a later episode. To submit your questions, email communicationstaff@asds.net.
For many, the holiday season is celebrated through music. Minneapolis musician Ben Cook-Feltz wrote an entire album to celebrate with. In one song, he pays tribute to frosty nights, meals with loved ones; in another, he hypes up Christmas vacation. He will celebrate Sunday with his fourth-annual “Holiday Shindig” at the Cedar Cultural Center.The celebration has a special meaning for Ben: he is a childhood cancer survivor and is donating proceeds from the event to Rein in Sarcoma, an organization that benefits people with sarcoma, a rare bone and tissue cancer. He joins MPR News host Nina Moini to share some of his music.
Breakthroughs in the Treatment of Sickle Cell Disease with guest Dr. Cece Calhoun, December 1, 2024
Welcome to Season 2 of the Orthobullets Podcast. Today's show is Core, where we review Core Knowledge for Orthopaedic Surgeons. This episode will cover the topic of Synovial Sarcoma, from our Pathology section at Orthobullets.com. Follow Orthobullets on Social Media: Facebook Instagram Twitter LinkedIn YouTube
Carley Rutledge went through much of 2010 in pain but not getting any correct answers about the cause of this pain for most of that year, until she received the shocking diagnosis of Ewings Sarcoma. Carley went through 2 years of difficult treatment and then was given an immunotherapy drug that worked and she experienced 8 years of being cancer free from this form of Pediatric Bone Cancer. Always active and with many accomplishments, Carley then felt back pain during her run in a Half Marathon which unfortunately indicated her Ewings Sarcoma had relapsed, and this led to her passing in November of 2021 at the age of 27. Carley's mother Laura will talk about her beloved daughter and about her family's Rutledge Cancer Foundation on today's podcast.
Welcome to the Orthobullets Podcasts. Today's show is Total Recall, where we review all of the highest yield points for anyone studying for the Orthopedic in Training Exam or part one of the ABOS Board Exam. Today's episode will cover the topic of Synovial Sarcoma from the Pathology section at Orthobullets.com. Follow Orthobullets on Social Media: Facebook Instagram Twitter LinkedIn YouTube
2024 is the year today's Raise the Line guest, Michelle Hughes, is supposed to die. That's according to the diagnosis she received three years ago from an oncologist who told her she had a rare, incurable form of cancer that had already caused innumerable tumors throughout her body. As a mother of three – with her youngest child being just a few weeks old at the time of her diagnosis – this was obviously devastating news. But fortunately, the optimism and encouragement of a second oncologist allowed for a new path forward. “It changed my entire world when that one doctor had hope,” she tells host Lindsey Smith.Fueled by the advice of her new doctor “to just live your life” Michelle embraced a healthy lifestyle that includes distance running, including a recently completed triathlon. She has also embraced the role of empowering others to face their challenges through “My Journey to Just Live” an organization she created that keeps her busy doing a blog, social media posts, speaking engagements fundraisers and other activities. Join us for a special edition of our Year of the Zebra series focused on rare diseases to learn about Michelle's challenging journey to motherhood, being a parent to three young children, and living with terminal cancer. “I remind my children and myself that cancer doesn't define me. I'm so much more than that.”For information on the November 16th online premiere of a documentary about Michelle's story, visit My Journey to Just Live
Welcome to Season 2 of the Orthobullets Podcast. Today's show is Foundations, where we review foundational knowledge for frontline MSK providers such as junior orthopaedic residents, ER physicians, and primary care providers. This episode will cover the topic of Soft Tissue Sarcoma, from our Pathology section at Orthobullets.com. Follow Orthobullets on Social Media: Facebook Instagram Twitter LinkedIn YouTube
Artificial intelligence continues to gain popularity as society identifies its uses and benefits. AI has shown promise despite being in the early phases of implementation in sarcoma care. For this episode we discuss Artificial intelligence, its present and the future in sarcoma care. Bozzo A, Tsui JMG, Bhatnagar S, Forsberg J. Deep Learning and Multimodal Artificial Intelligence in Orthopaedic Surgery. J Am Acad Orthop Surg. 2024 Jun 1;32(11):e523-e532. Bozzo, A., Hollingsworth, A., Chatterjee, S. et al. A multimodal neural network with gradient blending improves predictions of survival and metastasis in sarcoma. npj Precis. Onc. 8, 188 (2024). sarcomaAIhub.com Find out More about our Doctors: Dr. Izuchukwu Ibe: www.linkedin.com/in/izuchukwu-ibe-a073537a/ Dr. Elyse Brinkmann: www.linkedin.com/in/elyse-brinkmann/
In this episode Mo sits down with 2 time cancer survivor and Army Veteran, Alanzo to discuss his life story & his experience navigating life after being diagnosed with one of the rarest forms of cancer Synovial Sarcoma. Tune In!
Robert and Melanie Ham were young, with two young children when Melanie was diagnosed with an incurable rare form of Sarcoma in 2020. Robert, an award winning film maker and military veteran, decided he wanted to document her journey, their love, to help others. The documentary aired in 2022 after Melanie's death and has been viewed more than 1 million times on YouTube. Robert knew that a part of his grief journey included finding a way forward for himself and his children. That mean, not giving up on love and the lessons it teaches us. Enter Brooke. Brooke had been battling her own hard grief journey after her marriage ended in divorce. With two children of her own, Brooke had to find a way to balance single motherhood while also redefining what life was to look like for her. Brooke knew that she never wanted to give up on love, because a life without love is only half a life. This is a story of love, of hope, of longing, of enduring memory. Listen now! Or watch the video episode on our YouTube channel. Premier Sponsors: GammaTile Therapy Imvax Inc. Episode sponsors: Mimivax Inc. Alliance Advisory Group
Join U.S. Army National Guard Veteran Sean Claiborne as he hosts a powerful episode of America's Heroes Group, featuring a discussion on the Sarcoma Foundation of America. Special guest Amethyst, a Stellar Award-winning gospel singer, shares her deeply personal journey of losing her sister to sarcoma, while launching her latest album, An Amethyst Symphony. Also on the panel are Tasha Nathan, Program Manager for Engagement & Advocacy, and Brandi Felser, CEO of the Sarcoma Foundation of America, who bring expert insights on sarcoma, treatment challenges, and the fight for increased research and awareness. This is a must-watch for those looking to understand rare cancers, find hope, and witness the healing power of music.
In January of his senior year, Thomas was stretching and noticed a painless bump on the back of his hamstring. The 3-sport athlete thought nothing of it. But by the spring, the lump had grown to the size of a baseball. Thomas was immediately directed to Siteman kids where Washington University pediatric oncologist, Dr. Amy Armstrong, confirmed the mass was a sarcoma. Listen as Thomas, his mom Amelia, and Dr. Armstrong describe the long, intense treatment plan that delayed his plans for college football, and the mental grit it took to return to the sport he loved. Thomas also shares the advice he has for other young athletes. After a diagnosis, every Siteman patient and their medical team develops a treatment plan, and every treatment plan becomes as unique as the patient it supports. Chuck learned how to tailor a treatment plan firsthand as he acted as a caregiver to his son, and again when he faced a cancer diagnosis himself. In this episode, Chuck shares his experience alongside Tate Rondot, Siteman's Manager of Support Services. Both are involved in Siteman's Patient and Family Advisory Council (PFAC), a group dedicated to helping every patient create the plan they need during their cancer care. They offer considerations and resources that personalize patients' treatment from diagnosis to hospice and every stage in between. “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO. For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/specialized-programs/sarcoma/ https://www.stlouischildrens.org/conditions-treatments/childhood-cancer-survivorship-program https://www.stlouischildrens.org/conditions-treatments/oncology-services/proton-beam-therapy https://siteman.wustl.edu/treatment/cancer-types/childhood-cancers/ https://siteman.wustl.edu/visiting/kids/ https://siteman.wustl.edu/doctor/armstong-amy/ https://siteman.wustl.edu/treatment/cancer-types/sarcoma/
In this episode Nurse John invites Steve De Petrillo, the co-founder of Garde-Malade Scrubs. Steve was diagnosed with Sarcoma and found himself between life and death in the hospital. With the help of nurses and other healthcare workers, he won the battle and is currently on remission with the help of his wife Marie, the CEO of Garde-Malade, they found a way to give back to those who gave them healing, caring, and loving hands during the most difficult time of their lives. Bestie let's dive into this inspiring and million-dollar worthy story. Do me the biggest favour bestie, by giving us a 5 star in Spotify & Apple podcast, and to other platforms you're listening to, follow our podcast, leave a comment, turn on notification and share it to your social, it will help us spread the love and get us going! Follow me here: TikTok: https://www.tiktok.com/@nurse.johnn Instagram: https://instagram.com/nurse.johnn YouTube: https://youtube.com/@NurseJohnn Facebook: https://www.facebook.com/nurse.johnn Spotify: https://open.spotify.com/show/7Hp3DBH... Apple: https://podcasts.apple.com/ca/podcast... Check out my merch and get yourself one bestie! https://nursejohnn.com